This is unpublished
SLEEP-HD
Completed Studies
Dialysis
Pinned
Principal Investigator
Rajnish Mehrotra
Funding Agency
NIDDK
Status
Completed
back to page outline
Investigator
What is the SLEEP-HD Study?
This is a parallel group randomized controlled trial looking at insomnia in the dialysis population. 126 hemodialysis patients will be enrolled in community-based dialysis facilities in Seattle and New Mexico and randomized to 6 week treatment to telehealth cognitive based therapy, trazodone, or medication placebo. Response to treatment will be assessed after 6 weeks of treatment, and persistence of treatment effect will be ascertained at 25 weeks.
Publication
"Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis : A Randomized Clinical Trial"
Annals of Internal Medicine
2024 Feb;177(2):177-188.
doi: 10.7326/M23-1794. Epub 2024 Jan 16.